Table 2.
Genotype and allele frequency of APOA1 and APOC3 polymorphisms in subjects with metabolic syndrome (MetS) cases and controls: Tehran Lipid and Glucose Study
| With MetS (n=414) | without MetS (n=414) | p-value | |
|---|---|---|---|
| Allele frequency rs670 | 0.12 | ||
| G | 589(71)* | 604(73) | |
| A | 239(29) | 227(27) | |
| Genotype frequency rs670 | 0.62 | ||
| GG | 186(45) | 197(47) | |
| GA | 217(52) | 210(51) | |
| AA | 11(3) | 7(2) | |
| Allele frequency rs5069 | 0.12 | ||
| C | 648(78) | 654(79) | |
| T | 180(22) | 174(21) | |
| Genotype frequency rs5069 | 0.65 | ||
| CC | 258(62) | 259(62) | |
| CT | 132(32) | 136(33) | |
| TT | 24(6) | 19(5) | |
| Allele frequency rs5128 | 0.20 | ||
| C | 645(81) | 655(81) | |
| G | 155(19) | 157(19) | |
| Genotype frequency rs5128 | 0.76 | ||
| CC | 261(65) | 261(44) | |
| CG | 123(31) | 133(33) | |
| GG | 16(4) | 12(3) |
*
n(%)